A. Shuldiner

Publications408
h-index85
Citations27,214
Highly Influential Citations1,192
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • E. Boerwinkle
  • 1,337 Publications, 118,153 Citations
  • B. Mitchell
  • 579 Publications, 37,810 Citations
  • A. Uitterlinden
  • 1,204 Publications, 123,249 Citations
  • M. McCarthy
  • 955 Publications, 128,422 Citations
  • Publications
  • Influence
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
To identify genetic variants influencing plasma lipid concentrations, we first used genotype imputation and meta-analysis to combine three genome-wide scans totaling 8,816 individuals and comprising… Expand
  • 1,463
  • 87
  • Open Access
Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.
Central (visceral) obesity is more closely associated with insulin resistance, type 2 diabetes, and cardiovascular disease than is peripheral [subcutaneous (sc)] obesity, but the underlying mechanism… Expand
  • 640
  • 52
  • Open Access
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Elevated serum urate concentrations can cause gout, a prevalent and painful inflammatory arthritis. By combining data from >140,000 individuals of European ancestry within the Global Urate Genetics… Expand
  • 493
  • 52
  • Open Access
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
Cytochrome P450 (CYP)2C19 catalyzes the bioactivation of the antiplatelet prodrug clopidogrel, and CYP2C19 loss‐of‐function alleles impair formation of active metabolites, resulting in reduced… Expand
  • 554
  • 42
  • Open Access
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
BACKGROUND Common polymorphisms of the transcription factor 7-like 2 gene (TCF7L2) have recently been associated with type 2 diabetes. We examined whether the two most strongly associated variants… Expand
  • 724
  • 38
  • Open Access
Omentin Plasma Levels and Gene Expression Are Decreased in Obesity
Central obesity and the accumulation of visceral fat are risk factors for the development of type 2 diabetes and cardiovascular disease. Omentin is a protein expressed and secreted from visceral but… Expand
  • 558
  • 35
  • Open Access
Telomere length is paternally inherited and is associated with parental lifespan
Telomere length (TL) is emerging as a biomarker for aging and survival. To evaluate factors influencing this trait, we measured TL in a large homogeneous population, estimated the heritability (h2),… Expand
  • 313
  • 26
  • Open Access
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy
CYP2C19 is one of the principal enzymes involved in the bioactivation of the antiplatelet prodrug clopidogrel. A common loss‐of‐function allele, CYP2C19*2 (c.681G>A; rs4244285), is associated with… Expand
  • 371
  • 24
  • Open Access
Unique lipoprotein phenotype and genotype associated with exceptional longevity.
CONTEXT Individuals with exceptional longevity have a lower incidence and/or significant delay in the onset of age-related disease, and their family members may inherit biological factors that… Expand
  • 519
  • 23
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Apolipoprotein C-III (apoC-III) inhibits triglyceride hydrolysis and has been implicated in coronary artery disease. Through a genome-wide association study, we have found that about 5% of the… Expand
  • 517
  • 22